Amlodipine Besylate Tablets IP 2.5 mg Manufacturer in India – Healthy Life Pharma Pvt. Ltd.

Amlodipine Besylate Tablets IP 2.5 mg | Manufacturer
Product image for Amlodipine Besylate Tablets IP 2.5 mg Manufacturer; contract manufacturing, oem & quality control.
Product Information
| Generic Name | Amlodipine Besylate |
|---|---|
| Manufacturer | Healthy Life Pharma Pvt. Ltd. |
| HSN Code | 30049072 |
| Pharmacopoeia | IP |
| Product Type | Tablet |
| Category | Antihypertensive drugs – Calcium Channel Blocker |
| Subcategory | Calcium Channel Blocker |
| Active Ingredient | Amlodipine Besylate |
| Strength | 2.5 mg |
| Dosage Form | Tablet |
| Pack Size | 10 x 10 Tablets / Box (Alu-Alu / Blister) |
| Route of Administration | Oral |
| Prescription Required | Yes |
| Therapeutic Category | Antihypertensive drugs – Calcium Channel Blocker |
Medicine Details & Safety
| Short Description | Healthy Life Pharma invites contract and third-party manufacturing enquiries for Amlodipine Besylate Tablets IP 2.5 mg from pharmaceutical marketing companies, institutional buyers and brand owners. Production specifications, batch size and packaging are agreed against the approved product dossier and purchase requirements. | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Approved Uses / Indications | 1. First-line management of mild, moderate, and severe essential hypertension. 2. Adjunctive treatment in chronic stable angina pectoris and reduction of cardiovascular mortality. | ||||||||||||||||||||||||
| Full Description | Healthy Life Pharma invites contract and third-party manufacturing enquiries for Amlodipine Besylate Tablets IP 2.5 mg from pharmaceutical marketing companies, institutional buyers and brand owners. Production specifications, batch size and packaging are agreed against the approved product dossier and purchase requirements. Product technical specifications
Product technical specifications
Manufacturing capabilities and infrastructureFor Amlodipine Besylate Tablets IP 2.5 mg, assess the approved formulation process, equipment suitability, batch scale and in-process controls for the Tablet presentation. Confirm environmental requirements and validated process before production.Quality control and assuranceRequest the approved finished-product specification for Amlodipine Besylate Tablets IP 2.5 mg, including applicable identity, assay, uniformity and performance tests for the Tablet presentation. Confirm analytical methods, acceptance criteria and batch release documentation, including COA availability.Primary and secondary packagingThe catalogue pack for Amlodipine Besylate Tablets IP 2.5 mg is 10 x 10 Tablets / Box (Alu-Alu / Blister). Confirm primary packaging compatibility, stability evidence, artwork, batch coding and leaflet requirements against the approved specification.Contract manufacturing and private labelSubmit the target market, strength, pharmacopoeial specification, forecast volume and brand artwork. Agree feasibility, batch size, quality agreement, production schedule and release criteria before execution. | ||||||||||||||||||||||||
| Dosage Instructions | Administer orally once or twice daily at the same time each day, with or without food. Do not discontinue abruptly; gradual downward titration is recommended under medical supervision. | ||||||||||||||||||||||||
| Side Effects | Common: Peripheral edema (ankle swelling), dizziness, headache, flushing, fatigue. Uncommon: Postural hypotension, palpitations, dyspepsia, dry cough, muscle cramps. Rare: Bradycardia, severe hypotension, syncope, hyperkalemia, angioedema. | ||||||||||||||||||||||||
| Warnings and Precautions | Hypotension Monitoring: Monitor seated blood pressure during initial titration. Electrolyte Balance: Periodically verify serum potassium and renal clearance in patients with underlying renal insufficiency. Heart Failure Caution: Use with careful clinical assessment in heart failure patients. | ||||||||||||||||||||||||
| Contraindications | 1. Hypersensitivity to Amlodipine Besylate or related cardiovascular agent classes. 2. Severe cardiogenic shock, second- or third-degree atrioventricular block without a pacemaker. 3. Clinically severe hypotension (systolic BP < 90 mmHg). 4. Pregnancy and lactation (for ACE inhibitors and ARBs). | ||||||||||||||||||||||||
| Drug Interactions | 1. Other Antihypertensives & Diuretics: Additive blood-pressure-lowering effects requiring monitored dose titration. 2. Potassium Supplements & Potassium-Sparing Diuretics: Elevated risk of hyperkalemia (with RAAS blockers). 3. NSAIDs: May diminish antihypertensive response and increase risk of acute renal dysfunction. |
Frequently Asked Questions
| Question | Answer |
|---|---|
| Can I request third-party manufacturing for Amlodipine Besylate Tablets IP 2.5 mg? | Submit your brand, quantity and packaging requirements for manufacturing feasibility review. |
| Which pharmacopoeial standard applies for Amlodipine Besylate Tablets IP 2.5 mg? | The source specification is IP; confirm the required standard before contracting. |
| What quality tests are applicable for Amlodipine Besylate Tablets IP 2.5 mg? | Request the approved finished-product specification and batch testing plan. |
| Can packaging be customized for Amlodipine Besylate Tablets IP 2.5 mg? | Submit artwork and pack requirements for technical and regulatory review. |
| How do I request a manufacturing quotation for Amlodipine Besylate Tablets IP 2.5 mg? | Provide forecast volume, target market, strength and packaging requirements. |
Related Products
✚
Amlodipine Besylate Tablets IP 2.5 mg ExporterView product →
✚
Amlodipine Besylate Tablets IP 2.5 mg SupplierView product →
✚
Amlodipine Besylate Tablets IP 5 mg ExporterView product →
✚
Amlodipine Besylate Tablets IP 5 mg ManufacturerView product →
✚
Amlodipine Besylate Tablets IP 5 mg SupplierView product →
✚
Amlodipine Tablets 10 mg ExporterView product →
✚
Amlodipine Tablets 10 mg ManufacturerView product →
✚
Amlodipine Tablets 10 mg SupplierView product →
✚
Amlodipine Tablets 2.5 mg ExporterView product →
✚
Amlodipine Tablets 2.5 mg ManufacturerView product →
✚
Amlodipine Tablets 2.5 mg SupplierView product →
✚
Amlodipine Tablets 5 mg ExporterView product →
Latest Posts
✚
WHO GMP certfied Glibenclamide Metformin SR TabletsRead article →✚
WHO GMP certfied Frusemide Tablets ManufacturerRead article →✚
Folic Acid Niacinamide Tablets ManufacturerRead article →✚
WHO GMP certfied Folic Acid Tablets ManufacturerRead article →✚
WHO GMP certfied Fluconazole Tablets ManufacturerRead article →✚
WHO GMP certfied Ferrous Sulphate with folic acid TabletsRead article →✚
WHO GMP certfied iron with folic acid Tablets ManufacturerRead article →✚
WHO GMP certfied Ferrous Sulphate Tablets ManufacturerRead article →